Effects of testosterone supplementation on markers of the metabolic syndrome and inflammation in hypogonadal men with the metabolic syndrome: The double-blinded placebo-controlled Moscow study

Clinical Endocrinology

Volumn 73, Issue 5, 2010, Pages 602-612

  Kalinchenko, Svetlana Y ^a   Tishova, Yuliya A ^a   Mskhalaya, George J ^b   Gooren, Louis J G ^c   Giltay, Erik J ^d   Saad, Farid ^e,f  

^a PEOPLES FRIENDSHIP UNIVERSITY OF RUSSIA   (Russian Federation)

^b Medical Clinic of Reproduction MAMA   (Russian Federation)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^e BAYER PHARMA AG   (Germany)

^f GULF MEDICAL UNIVERSITY   (United Arab Emirates)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; ESTRADIOL; HEMOGLOBIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; LEPTIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; LUTEINIZING HORMONE; PLACEBO; PROSTATE SPECIFIC ANTIGEN; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE; TESTOSTERONE UNDECANOATE; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ANDROGEN THERAPY; ARTICLE; BILIRUBIN BLOOD LEVEL; BODY MASS; BODY WEIGHT; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; GLUCOSE BLOOD LEVEL; HEMATOCRIT; HEMATOPOIESIS; HORMONE BLOOD LEVEL; HUMAN; HYPOGONADISM; INFLAMMATION; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHASE 3 CLINICAL TRIAL; PRIORITY JOURNAL; PROSTATE; RANDOMIZED CONTROLLED TRIAL; RUSSIAN FEDERATION; TESTOSTERONE BLOOD LEVEL; WAIST CIRCUMFERENCE; WAIST HIP RATIO;

ADULT; AGED; BODY MASS INDEX; C-REACTIVE PROTEIN; HUMANS; HYPOGONADISM; INFLAMMATION; INSULIN; INTERLEUKIN-10; INTERLEUKIN-6; LEPTIN; LIPIDS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; TESTOSTERONE; TUMOR NECROSIS FACTOR-ALPHA; WAIST CIRCUMFERENCE; WAIST-HIP RATIO;

EID: 78449294931     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2010.03845.x     Document Type: Article

References (66)

1. Corona, G., Forti, G., &, Maggi, M., (2008) Why can patients with erectile dysfunction be considered lucky? The association with testosterone deficiency and metabolic syndrome Aging Male, 11, 193 - 199.
2. Traish, A.M., Saad, F., &, Guay, A., (2009) The dark side of testosterone deficiency: II. Type 2 diabetes and insulin resistance. Journal of Andrology, 30, 23 - 32.
3. Yassin, A.A., Saad, F., &, Gooren, L.J., (2008) Metabolic syndrome, testosterone deficiency and erectile dysfunction never come alone. Andrologia, 40, 259 - 264.
4. Laughlin, G.A., Barrett-Connor, E., &, Bergstrom, J., (2008) Low serum testosterone and mortality in older men. The Journal of Clinical Endocrinology and Metabolism, 93, 68 - 75.
5. Shores, M.M., Matsumoto, A.M., Sloan, K.L., et al. (2006) Low serum testosterone and mortality in male veterans. Archives of Internal Medicine, 166, 1660 - 1665.
6. Shores, M.M., Moceri, V.M., Gruenewald, D.A., et al. (2004) Low testosterone is associated with decreased function and increased mortality risk: a preliminary study of men in a geriatric rehabilitation unit. Journal of the American Geriatrics Society, 52, 2077 - 2081.
7. Khaw, K.T., Dowsett, M., Folkerd, E., et al. (2007) Endogenous testosterone and mortality due to all causes, cardiovascular disease, and cancer in men: European prospective investigation into cancer in Norfolk (EPIC-Norfolk) Prospective Population Study. Circulation, 116, 2694 - 2701.
8. Maggio, M., Lauretani, F., Ceda, G.P., et al. (2007) Relationship between low levels of anabolic hormones and 6-year mortality in older men: the aging in the Chianti Area (InCHIANTI) study. Archives of Internal Medicine, 167, 2249 - 2254.
9. Kaplan, S.A., Meehan, A.G., &, Shah, A., (2006) The age related decrease in testosterone is significantly exacerbated in obese men with the metabolic syndrome. What are the implications for the relatively high incidence of erectile dysfunction observed in these men? Journal of Urology, 176, 1524 - 1527; discussion 1527-1528.
10. Allan, C.A., Strauss, B.J., Burger, H.G., et al. (2006) The association between obesity and the diagnosis of androgen deficiency in symptomatic ageing men. The Medical Journal of Australia, 185, 424 - 427.
11. Kalyani, R.R., &, Dobs, A.S., (2007) Androgen deficiency, diabetes, and the metabolic syndrome in men. Current Opinion Endocrinology, Diabetes, and Obesity, 14, 226 - 234.
12. Allan, C.A., Strauss, B.J., &, McLachlan, R.I., (2007) Body composition, metabolic syndrome and testosterone in ageing men. International Journal of Impotence Research, 19, 448 - 457.
13. Mohr, B.A., Bhasin, S., Link, C.L., et al. (2006) The effect of changes in adiposity on testosterone levels in older men: longitudinal results from the Massachusetts Male Aging Study. European Journal of Endocrinology 155, 443 - 452.
14. Svartberg, J., Von Muhlen, D., Sundsfjord, J., et al. (2004) Waist circumference and testosterone levels in community dwelling men. The Tromso study. European Journal of Epidemiology, 19, 657 - 663.
15. Kaufman, J.M., &, Vermeulen, A., (2005) The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocrine Reviews, 26, 833 - 876.
16. Eckel, R.H., Grundy, S.M., &, Zimmet, P.Z., (2005) The metabolic syndrome. Lancet, 365, 1415 - 1428.
17. Lima, N., Cavaliere, H., Knobel, M., et al. (2000) Decreased androgen levels in massively obese men may be associated with impaired function of the gonadostat. International Journal of Obesity and Related Metabolic Disorders, 24, 1433 - 1437.
18. Pitteloud, N., Hardin, M., Dwyer, A.A., et al. (2005) Increasing insulin resistance is associated with a decrease in Leydig cell testosterone secretion in men. The Journal of Clinical Endocrinology and Metabolism, 90, 2636 - 2641.
19. Isidori, A.M., Caprio, M., Strollo, F., et al. (1999) Leptin and androgens in male obesity: evidence for leptin contribution to reduced androgen levels. The Journal of Clinical Endocrinology and Metabolism, 84, 3673 - 3680.
20. Lyon, C.J., Law, R.E., &, Hsueh, W.A., (2003) Minireview: adiposity, inflammation and atherogenesis. Endocrinology, 144, 2195 - 2200.
21. Trayhurn, P., &, Wood, I.S., (2004) Adipokines: inflammation and the pleiotropic role of whte adipose tissue. The British Journal of Nutrition, 92, 347 - 355.
22. Stellato, R.K., Feldman, H.A., Hamdy, O., et al. (2000) Testosterone, sex hormone-binding globulin, and the development of type 2 diabetes in middle-aged men: prospective results from the Massachusetts male aging study. Diabetes Care, 23, 490 - 494.
23. Laaksonen, D.E., Niskanen, L., Punnonen, K., et al. (2004) Testosterone and sex hormone-binding globulin predict the metabolic syndrome and diabetes in middle-aged men. Diabetes Care, 27, 1036 - 1041.
24. Smith, M.R., Lee, H., &, Nathan, D.M., (2006) Insulin sensitivity during combined androgen blockade for prostate cancer. The Journal of Clinical Endocrinology and Metabolism, 91, 1305 - 1308.
25. Basaria, S., Muller, D.C., Carducci, M.A., et al. (2006) Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer, 106, 581 - 588.
26. Braga-Basaria, M., Dobs, A.S., Muller, D.C., et al. (2006) Metabolic syndrome in men with prostate cancer undergoing long-term androgen-deprivation therapy. Journal of Clinical Oncology, 24, 3979 - 3983. (Pubitemid 46630747)
27. Yialamas, M.A., Dwyer, A.A., Hanley, E., et al. (2007) Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. The Journal of Clinical Endocrinology and Metabolism, 92, 4254 - 4259.
28. Haidar, A., Yassin, A., Saad, F., et al. (2007) Effects of androgen deprivation on glycaemic control and on cardiovascular biochemical risk factors in men with advanced prostate cancer with diabetes. Aging Male, 10, 189 - 196.
29. Maggio, M., Basaria, S., Ble, A., et al. (2006) Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. The Journal of Clinical Endocrinology and Metabolism, 91, 345 - 347.
30. Nettleship, J.E., Pugh, P.J., Channer, K.S., et al. (2007) Inverse relationship between serum levels of interleukin-1beta and testosterone in men with stable coronary artery disease. Hormone and Metabolic Research. Hormon- und Stoffwechselforschung, 39, 366 - 371.
31. Malkin, C.J., Pugh, P.J., Jones, R.D., et al. (2004) The effect of testosterone replacement on endogenous inflammatory cytokines and lipid profiles in hypogonadal men. The Journal of Clinical Endocrinology and Metabolism, 89, 3313 - 3318.
32. Yudkin, J.S., (2007) Inflammation, obesity, and the metabolic syndrome. Hormone and Metabolic Research, 39, 707 - 709.
33. Scherer, P.E., (2006) Adipose tissue: from lipid storage compartment to endocrine organ. Diabetes, 55, 1537 - 1545.
34. Lee, D.E., Kehlenbrink, S., Lee, H., et al. (2009) Getting the message across: mechanisms of physiological cross talk by adipose tissue. American Journal of Physiology. Endocrinology and Metabolism, 296, E1210 - E1229.
35. Schaffler, A., Muller-Ladner, U., Scholmerich, J., et al. (2006) Role of adipose tissue as an inflammatory organ in human diseases. Endocrine Reviews, 27, 449 - 467.
36. Kershaw, E.E., &, Flier, J.S., (2004) Adipose tissue as an endocrine organ. The Journal of Clinical Endocrinology and Metabolism, 89, 2548 - 2556.
37. Laaksonen, D.E., Niskanen, L., Punnonen, K., et al. (2003) Sex hormones, inflammation and the metabolic syndrome: a population-based study. European Journal of Endocrinology 149, 601 - 608.
38. Corrales, J.J., Almeida, M., Burgo, R., et al. (2006) Androgen-replacement therapy depresses the ex vivo production of inflammatory cytokines by circulating antigen-presenting cells in aging type-2 diabetic men with partial androgen deficiency. The Journal of Endocrinology, 189, 595 - 604.
39. Kapoor, D., Clarke, S., Stanworth, R., et al. (2007) The effect of testosterone replacement therapy on adipocytokines and C-reactive protein in hypogonadal men with type 2 diabetes. European Journal of Endocrinology 156, 595 - 602.
40. Singh, R., Artaza, J.N., Taylor, W.E., et al. (2006) Testosterone inhibits adipogenic differentiation in 3T3-L1 cells: nuclear translocation of androgen receptor complex with beta-catenin and T-cell factor 4 may bypass canonical Wnt signaling to down-regulate adipogenic transcription factors. Endocrinology, 147, 141 - 154.
41. Goncharov, N.P., Katsya, G.V., Chagina, N.A., et al. (2008) Three definitions of metabolic syndrome applied to a sample of young obese men and their relation with plasma testosterone. Aging Male, 11, 118 - 122.
42. Saad, F., Gooren, L.J., Haider, A., et al. (2008) A dose-response study of testosterone on sexual dysfunction and features of the metabolic syndrome using testosterone gel and parenteral testosterone undecanoate. Journal of Andrology, 29, 102 - 105.
43. Munzer, T., Harman, S.M., Hees, P., et al. (2001) Effects of GH and/or sex steroid administration on abdominal subcutaneous and visceral fat in healthy aged women and men. The Journal of Clinical Endocrinology and Metabolism, 86, 3604 - 3610.
44. Schroeder, E.T., Zheng, L., Ong, M.D., et al. (2004) Effects of androgen therapy on adipose tissue and metabolism in older men. The Journal of Clinical Endocrinology and Metabolism, 89, 4863 - 4872.
45. La Vignera, S., Calogero, A.E., D'Agata, R., et al. (2008) Testosterone therapy improves the clinical response to conventional treatment for male patients with metabolic syndrome associated to late onset hypogonadism. Minerva Endocrinologica, 33, 159 - 167.
46. Allan, C.A., Strauss, B.J., Burger, H.G., et al. (2008) Testosterone therapy prevents gain in visceral adipose tissue and loss of skeletal muscle in nonobese aging men. The Journal of Clinical Endocrinology and Metabolism, 93, 139 - 146.
47. Page, S.T., Amory, J.K., Bowman, F.D., et al. (2005) Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T. The Journal of Clinical Endocrinology and Metabolism, 90, 1502 - 1510.
48. Heufelder, A.E., Saad, F., Bunck, M.C., et al. (2009) Fifty-two-week treatment with diet and exercise plus transdermal testosterone reverses the metabolic syndrome and improves glycemic control in men with newly diagnosed type 2 diabetes and subnormal plasma testosterone. Journal of Andrology, 30, 726 - 733.
49. Alberti, K.G., Zimmet, P., &, Shaw, J., (2005) The metabolic syndrome - a new worldwide definition. Lancet, 366, 1059 - 1062. (Pubitemid 41338752)
50. Wang, C., Nieschlag, E., Swerdloff, R.S., et al. (2009) ISA, ISSAM, EAU, EAA and ASA recommendations: investigation, treatment and monitoring of late-onset hypogonadism in males. Aging Male, 12, 5 - 12.
51. Grundy, S.M., Brewer, Jr.H.B., &, Cleeman, J.I., (2004) Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition. Circulation, 109, 433 - 438.
52. Vermeulen, A., Verdonck, L., &, Kaufman, J.M., (1999) A critical evaluation of simple methods for the estimation of free testosterone in serum. The Journal of Clinical Endocrinology and Metabolism, 84, 3666 - 3672.
53. Wallace, T.M., Levy, J.C., &, Matthews, D.R., (2004) Use and abuse of HOMA modeling. Diabetes Care, 27, 1487 - 1495.
54. Traish, A.M., Guay, A., Feeley, R., et al. (2009) The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction. Journal of Andrology, 30, 10 - 22.
55. Stanworth, R.D., &, Jones, T.H., (2009) Testosterone in obesity, metabolic syndrome and type 2 diabetes. Frontiers of Hormone Research, 37, 74 - 90.
56. Hakimian, P., Blute, Jr.M., &, Kashanian, J., et al. (2008) Metabolic and cardiovascular effects of androgen deprivation therapy. BJU International, 102, 1509 - 1514.
57. Huxley, R., Mendis, S., Zheleznyakov, E., et al. (2010) Body mass index, waist circumference and waist:hip ratio as predictors of cardiovascular risk-a review of the literature. European Journal of Clinical Nutrition, 64, 16 - 22.
58. Franco, O.H., Massaro, J.M., Civil, J., et al. (2009) Trajectories of entering the metabolic syndrome: the framingham heart study. Circulation, 120, 1943 - 1950.
59. Von Eckardstein, S., &, Nieschlag, E., (2002) Treatment of male hypogonadism with testosterone undecanoate injected at extended intervals of 12 weeks: a phase II study. Journal of Andrology, 23, 419 - 425.
60. Haider, A., Gooren, L.J., Padungtod, P., et al. (2009) Concurrent improvement of the metabolic syndrome and lower urinary tract symptoms upon normalisation of plasma testosterone levels in hypogonadal elderly men. Andrologia, 41, 7 - 13.
61. Ding, E.L., Song, Y., Manson, J.E., et al. (2009) Sex hormone-binding globulin and risk of type 2 diabetes in women and men. The New England Journal of Medicine, 361, 1152 - 1163.
62. Hajamor, S., Despres, J.P., Couillard, C., et al. (2003) Relationship between sex hormone-binding globulin levels and features of the metabolic syndrome. Metabolism, 52, 724 - 730.
63. Sattler, F.R., Castaneda-Sceppa, C., Binder, E.F., et al. (2009) Testosterone and growth hormone improve body composition and muscle performance in older men. The Journal of Clinical Endocrinology and Metabolism, 94, 1991 - 2001.
64. Boyanov, M.A., Boneva, Z., &, Christov, V.G., (2003) Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency. Aging Male, 6, 1 - 7.
65. Haider, A., Gooren, L.J., Padungtod, P., et al. (2009) Improvement of the metabolic syndrome and of non-alcoholic liver steatosis upon treatment of hypogonadal elderly men with parenteral testosterone undecanoate. Experimental and Clinical Endocrinology & Diabetes, 118, 167 - 171.
66. Marks, L.S., Mazer, N.A., Mostaghel, E., et al. (2006) Effect of testosterone replacement therapy on prostate tissue in men with late-onset hypogonadism: a randomized controlled trial. JAMA, 296, 2351 - 2361.